AR-V7-targeted PROTAC protein degrader program (Arvinas)

N/A

Report date: 2025/01/26 15:06:49
NME

Base Information

Drug NameAR-V7-targeted PROTAC protein degrader program (Arvinas)
Drug Alias Namenext generation AR PROTAC (Arvinas)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsHormone-Resistant Prostate Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArvinas Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Ag
Inactive CompaniesArvinas Inc
Active IndicationsHormone-Resistant Prostate Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A